The primary care clinician is increasingly called upon to manage a wide spectrum of psychiatric disorders from initial presentations of depression and anxiety to complex and chronic conditions such as bipolar disorder, addictions, and psychotic disorders. Psychopharmacology Review for Primary Care is a fast-paced, ambitious review of an array of topics including overview of drug classes, adverse effects, management of common clinical presentations, and clinical pearls. Our target audience will be prescribers wishing to enhance their knowledge and non-prescribers wishing to add to their knowledge base. A cased-based approach with audience interaction and emphasis on providing links to resources and clinical tools will enhance learning. Review will include mention of emerging topics in psychiatry the primary care team may receive questions about, such as ketamine, newer antidepressants, medical cannabis, and pharmacogenomic testing. All disciplines are welcome.
- Describe initial management of depressive, bipolar, and anxiety disorder clinical presentations to stabilize patients or bridge to psychiatric consultation.
- Identify and manage common and serious side effects of antidepressants, antipsychotics, and mood stabilizers and barriers to treatment.
- Identify and have access to at least three clinical tools/resources on psychopharmacology.
- Prim Care. 2016 Jun;43(2):327-40. doi: 10.1016/j.pop.2016.01.002.Psychopharmacology in Primary Care Settings.
- Ann Intern Med. 2016 Oct 4;165(7):ITC49-ITC64. doi: 10.7326/AITC201610040.
- Am J Med. 2019 Jan 30. pii: S0002-9343(19)30115-9. doi: 10.1016/j.amjmed.2019.01.012. [Epub ahead of print]. New Treatment Options for Depression: A Primer for Internists. Byun TH1, Chaliki SS2, Poole KG Jr2
- Med Clin North Am. 2014 Sep;98(5):1025-48. doi: 10.1016/j.mcna.2014.06.004.
- BMC Psychiatry. 2017 Feb 8;17(1):60. doi: 10.1186/s12888-017-1230-5.